| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $152,581,626 ) (Continued on the next page) |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K01HL149984 | Pharmacological Mechanistic Insights into Thoracic Aortic Aneurysm | 001 | 4 | NIH | 7/13/2024 | $75,600 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K01HL149984 | Pharmacological Mechanistic Insights into Thoracic Aortic Aneurysm | 000 | 4 | NIH | 12/21/2023 | $162,000 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU58DP007724 | EMPOWER: Empowering and Mobilizing Intergenerational Community Partners to Reduce Menthol & Flavored Tobacco Use Among At-risk Communities in Kentucky | 00 | 2 | CDC | 7/2/2024 | $375,000 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K23DK128562 | Classical and Alternative Renin-Angiotensin System Dysregulation in Sepsis-Associated AKI: A Reverse Translation Approach | 001 | 3 | NIH | 3/11/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K23DK128562 | Classical and Alternative Renin-Angiotensin System Dysregulation in Sepsis-Associated AKI: A Reverse Translation Approach | 000 | 3 | NIH | 11/21/2023 | $157,563 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DK128033 | Mirabegron and tadalafil effectiveness for treatment of prediabetes | 001 | 3 | NIH | 5/7/2024 | $18,360 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DK128033 | Mirabegron and tadalafil effectiveness for treatment of prediabetes | 000 | 3 | NIH | 12/15/2023 | $275,400 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01ES033767 | Phthalate-Induced Dysregulation of Prostaglandin and Angiogenic Function During Ovulation in Women | 000 | 3 | NIH | 10/23/2023 | $439,396 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K08DK124566 | Muscle bone interaction and its role in diabetic bone disease of Type I diabetes | 000 | 4 | NIH | 12/19/2023 | $164,517 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01ES034786 | Mechanisms of Sex-specific Metabolic Disruption Caused by Organophosphate Flame Retardant Exposure | 000 | 1 | NIH | 7/1/2024 | $429,135 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21NS135089 | Cannabidiol (CBD) as a Potential Therapeutic for Experimental Subarachnoid Hemorrhage | 000 | 1 | NIH | 12/5/2023 | $229,500 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | U54DA058256 | Appalachian Tobacco Regulatory Science Team (AppalTRuST) | 000 | 2 | NIH | 8/7/2024 | $3,866,213 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DK133076 | Origins of Skeletal Fragility in Type 1 Diabetes | 001 | 2 | NIH | 7/22/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | P01AG078116 | Strategies for targeting astrocyte reactivity in Alzheimer's disease and related dementias | 000 | 3 | NIH | 6/26/2024 | $4,131,531 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01NS079507 | Novel Therapeutic Strategies to Resolve Neurovascular Inflammation and Repair Blood-Brain Barrier Dysfunction in Epilepsy | 000 | 10 | NIH | 3/27/2024 | $513,784 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | T0830179 | Scholarships for Disadvantaged Students | 00 | 9 | HRSA | 5/24/2024 | $640,250 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01NS079507 | Novel Therapeutic Strategies to Resolve Neurovascular Inflammation and Repair Blood-Brain Barrier Dysfunction in Epilepsy | 001 | 10 | NIH | 4/11/2024 | $39,961 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DK133076 | Origins of Skeletal Fragility in Type 1 Diabetes | 000 | 2 | NIH | 5/20/2024 | $503,684 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | G08LM014412 | DASH-ing to Heart Health: Supporting Low-Income African American Women with an Interactive "Meals that Heal" Resource Book | 000 | 1 | NIH | 12/20/2023 | $118,770 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01HD101508 | Noninvasive Noncontact High-Density Optical Imaging of Neonatal Intraventricular Hemorrhage | 000 | 5 | NIH | 3/25/2024 | $484,427 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01HD101508 | Noninvasive Noncontact High-Density Optical Imaging of Neonatal Intraventricular Hemorrhage | 001 | 5 | NIH | 5/6/2024 | $48,444 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01CA266579 | Targeting Polo-Like Kinase 1 in Prostate Cancer to Enhance Therapeutic Efficacy | 000 | 3 | NIH | 6/7/2024 | $422,964 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R03HD113906 | Role of Long Non-coding RNAs in the Ovulatory Process | 000 | 1 | NIH | 8/16/2024 | $154,000 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | TL1TR001997 | NRSA Training Core | 002 | 8 | NIH | 8/16/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | TL1TR001997 | NRSA Training Core | 000 | 8 | NIH | 6/17/2024 | $486,219 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AI150767 | Structure and function of Burkholderia contact-dependent growth inhibition (CDI) systems | 000 | 5 | NIH | 8/13/2024 | $374,525 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R03HD113906 | Role of Long Non-coding RNAs in the Ovulatory Process | 001 | 1 | NIH | 8/19/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R13AI129382 | Autumn Immunology Conference | 000 | 6 | NIH | 10/20/2023 | $18,000 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | H7600719 | Ryan White Part C Outpatient EIS Program | 00 | 23 | HRSA | 1/26/2024 | $172,665 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R13AG081016 | Dysphagia: In Search of a Unified Definition for the Aging Population | 000 | 2 | NIH | 11/16/2023 | $45,657 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG068215 | Sleep Fragmentation and Alzheimer’s Disease | 000 | 5 | NIH | 5/22/2024 | $717,087 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R35GM155281 | Cellular and Molecular Determinants of Post-Burn Myopathy | 001 | 1 | NIH | 8/19/2024 | $2,185 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R35GM155281 | Cellular and Molecular Determinants of Post-Burn Myopathy | 000 | 1 | NIH | 7/18/2024 | $363,005 |
| | 2024 | 2024 | University of Kentucky Research Foundation, The | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | H7600719 | Ryan White Part C Outpatient EIS Program | 02 | 23 | HRSA | 8/6/2024 | $14,121 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | H7600719 | Ryan White Part C Outpatient EIS Program | 01 | 23 | HRSA | 6/6/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DK095662 | The Role of Crypt Fissioning in IBD Ulcer Healing | 001 | 13 | NIH | 2/8/2024 | $594,108 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DK095662 | The Role of Crypt Fissioning in IBD Ulcer Healing | 002 | 13 | NIH | 5/29/2024 | $39,607 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21CA285253 | Novel Strategy to Augmenting Immunotherapy against Melanoma | 000 | 1 | NIH | 2/29/2024 | $177,259 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21DA060354 | Regulation of cocaine use by astrocyte voltage-gated channels | 000 | 1 | NIH | 3/21/2024 | $183,859 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R25ES027684 | Summer Research in Environmental Health Sciences | 000 | 7 | NIH | 10/23/2023 | $135,000 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | 90DDUC0145 | University Centers for Excellence in Developmental Disabilities | 00 | 2 | ACL | 6/26/2024 | $620,675 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AR083375 | Mechanistic Assessment of NMES to Rescue Localized Neuromuscular Disruption after ACL Injury | 000 | 1 | NIH | 8/31/2024 | $488,782 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21AG088756 | Therapeutic Value of BNC-1 in Addressing Tau Pathology in TBI | 000 | 1 | NIH | 9/3/2024 | $423,500 |
| | 2024 | 2024 | University of Kentucky Research Foundation, The | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | D5837582 | Residency Training in Primary Care | 00 | 5 | HRSA | 5/9/2024 | $462,179 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F31MD019997 | From Survival to Living Well: A Socioecological Approach to Understand Acquired Disability and Advance Health Equity in Rural Appalachia | 000 | 1 | NIH | 9/3/2024 | $41,572 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG084180 | Impacting Inflammation through Mechanistic Target of Rapamycin (imTOR) | 000 | 1 | NIH | 8/30/2024 | $640,068 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01ES032396 | A university-community partnership to reduce exposure to disinfection byproducts in Appalachia | 000 | 4 | NIH | 11/3/2023 | $484,636 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | T7342028 | Leadership Education in Neurodevelopmental and Related Disorders Training Program | 00 | 4 | HRSA | 5/16/2024 | $464,000 |
| | 2024 | 2024 | University of Kentucky Research Foundation, The | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | U2W33312 | Medicare Rural Hospital Flexibility | 00 | 6 | HRSA | 7/26/2024 | $682,698 |
|
